Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone as Adjunctive Therapy for P.Falciparum Infection
NCT00149383Phase 2Completed
- Sponsor
- Mahidol University
- Start
- Dec 2004
- Primary completion
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rosiglitazone in Malaria, sponsored by Mahidol University. Started Dec 2004; status: completed.
02
Drugs
rosiglitazone
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT00149383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00149383.